Injection pressure levels for creating blebs during subretinal gene therapy.

Autor: Scruggs BA; Casey Eye Institute, Department of Ophthalmology, Oregon Health & Science University, Portland, OR, USA.; Department of Ophthalmology, Mayo Clinic, Rochester, MN, USA., Vasconcelos HM Jr; Casey Eye Institute, Department of Ophthalmology, Oregon Health & Science University, Portland, OR, USA.; Department of Ophthalmology, Federal University of São Paulo, São Paulo, Brazil., Matioli da Palma M; Casey Eye Institute, Department of Ophthalmology, Oregon Health & Science University, Portland, OR, USA.; Department of Ophthalmology, Federal University of São Paulo, São Paulo, Brazil., Kogachi K; Casey Eye Institute, Department of Ophthalmology, Oregon Health & Science University, Portland, OR, USA., Pennesi ME; Casey Eye Institute, Department of Ophthalmology, Oregon Health & Science University, Portland, OR, USA., Yang P; Casey Eye Institute, Department of Ophthalmology, Oregon Health & Science University, Portland, OR, USA., Bailey ST; Casey Eye Institute, Department of Ophthalmology, Oregon Health & Science University, Portland, OR, USA., Lauer AK; Casey Eye Institute, Department of Ophthalmology, Oregon Health & Science University, Portland, OR, USA. lauera@ohsu.edu.

Publikováno v: Gene therapy [Gene Ther] 2022 Nov; Vol. 29 (10-11), pp. 601-607. Date of Electronic Publication: 2021 Sep 28.